{"id":46214,"date":"2022-07-15T08:01:37","date_gmt":"2022-07-15T06:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/"},"modified":"2022-07-15T08:01:37","modified_gmt":"2022-07-15T06:01:37","slug":"endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/","title":{"rendered":"Endostart Appoints Christopher Rowland Chairman of the Company\u2019s Board of Directors."},"content":{"rendered":"
\n

CERTALDO (FLORENCE), Italy–(BUSINESS WIRE)–#colonoscopy<\/a>–The growth of Italian medical device start-up Endostart<\/a><\/b><\/span> continues with the appointment of Christopher Rowland, a global expert in the medical device industry, to Chairman of the company\u2019s Board of Directors.\n<\/p>\n

\nWith over 30 years of experience in positions of increasing responsibility in sales, product development, marketing, business development, and CEO leadership in the US and abroad, Chris brings an unrivaled experience and competency in a wide variety of clinical and commercial medical devices verticals, including gastroenterology, cardiology, urology, radiology, and peripheral vascular specialties.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nHis professional experience includes 17 years with Boston Scientific, ending as the Global VP of Marketing for the Endoscopy Division; he also served as President of Given Imaging Inc. (acquired by Covidien\/MDT) and President\/CEO of Neotract Inc. (acquired by Teleflex). Chris is also currently the President and CEO of Tricol Biomedical, a leader in hemostasis technology.\n<\/p>\n

\nIn his new role, Chris will work with and coordinate the Board of Directors for Endostart.\n<\/p>\n

\n\u201cWith his long history of leadership and his expertise in the digestive endoscopy industry, Chris is the ideal Chairman of the Board for Endostart,\u201d said Alessandro Tozzi, CEO and founder of Endostart. \u201cWe are certain that Chris will be a driving force in our success.\u201d\n<\/p>\n

\n\u201cI am excited to support the investors and the leadership team of this dynamic company. I believe Endostart is poised for significant growth reflecting demand for its innovative products to enhance endoscopic performance,\u201d said Mr. Rowland. \u201cI look forward to helping Endostart maximize shareholder value and realize its commercial potential.\u201d\n<\/p>\n

\nAbout Endorail\u2122<\/b>\n<\/p>\n

\nThe first product from Endostart is Endorail\u2122, an innovative medical device aimed at facilitating completion of colonoscopy procedures using Magnetic Balloon Technology. This technology is designed to enhance endoscope performance and enable endoscopists to easily achieve quality standards. Endorail received a CE mark in 2019 and has been tested in a clinical setting. It is not yet cleared by the US Food and Drug Administration (FDA).\n<\/p>\n

\nAbout Endostart<\/b>\n<\/p>\n

\nFounded in 2018, Endostart is focused on developing and manufacturing next-generation medical devices for gastrointestinal endoscopy. The company is ISO 13485 certified. It has an international board of directors and a strong medical advisory board. It recently announced a capital increase of \u20ac8.2M (USD $10M).\n<\/p>\n

\nWebsite: www.endostart.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nContact: info@endostart.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CERTALDO (FLORENCE), Italy–(BUSINESS WIRE)–#colonoscopy–The growth of Italian medical device start-up Endostart continues with the appointment of Christopher Rowland, a global expert in the medical device industry, to Chairman of the company\u2019s Board of Directors. With over 30 years of experience in positions of increasing responsibility in sales, product development, marketing, business development, and CEO leadership … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46214","6":"format-standard","7":"category-industry"},"yoast_head":"\nEndostart Appoints Christopher Rowland Chairman of the Company\u2019s Board of Directors. - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Endostart Appoints Christopher Rowland Chairman of the Company\u2019s Board of Directors. - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CERTALDO (FLORENCE), Italy–(BUSINESS WIRE)–#colonoscopy–The growth of Italian medical device start-up Endostart continues with the appointment of Christopher Rowland, a global expert in the medical device industry, to Chairman of the company\u2019s Board of Directors. With over 30 years of experience in positions of increasing responsibility in sales, product development, marketing, business development, and CEO leadership ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-15T06:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220714005706\/en\/1514191\/21\/ChrisRowland-_Chairman-_Endostart.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Endostart Appoints Christopher Rowland Chairman of the Company\u2019s Board of Directors.\",\"datePublished\":\"2022-07-15T06:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/\"},\"wordCount\":391,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005706\\\/en\\\/1514191\\\/21\\\/ChrisRowland-_Chairman-_Endostart.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/\",\"name\":\"Endostart Appoints Christopher Rowland Chairman of the Company\u2019s Board of Directors. - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005706\\\/en\\\/1514191\\\/21\\\/ChrisRowland-_Chairman-_Endostart.jpg\",\"datePublished\":\"2022-07-15T06:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005706\\\/en\\\/1514191\\\/21\\\/ChrisRowland-_Chairman-_Endostart.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005706\\\/en\\\/1514191\\\/21\\\/ChrisRowland-_Chairman-_Endostart.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Endostart Appoints Christopher Rowland Chairman of the Company\u2019s Board of Directors.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Endostart Appoints Christopher Rowland Chairman of the Company\u2019s Board of Directors. - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Endostart Appoints Christopher Rowland Chairman of the Company\u2019s Board of Directors. - Pharma Trend","og_description":"CERTALDO (FLORENCE), Italy–(BUSINESS WIRE)–#colonoscopy–The growth of Italian medical device start-up Endostart continues with the appointment of Christopher Rowland, a global expert in the medical device industry, to Chairman of the company\u2019s Board of Directors. With over 30 years of experience in positions of increasing responsibility in sales, product development, marketing, business development, and CEO leadership ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-15T06:01:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220714005706\/en\/1514191\/21\/ChrisRowland-_Chairman-_Endostart.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Endostart Appoints Christopher Rowland Chairman of the Company\u2019s Board of Directors.","datePublished":"2022-07-15T06:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/"},"wordCount":391,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220714005706\/en\/1514191\/21\/ChrisRowland-_Chairman-_Endostart.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/","url":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/","name":"Endostart Appoints Christopher Rowland Chairman of the Company\u2019s Board of Directors. - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220714005706\/en\/1514191\/21\/ChrisRowland-_Chairman-_Endostart.jpg","datePublished":"2022-07-15T06:01:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220714005706\/en\/1514191\/21\/ChrisRowland-_Chairman-_Endostart.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220714005706\/en\/1514191\/21\/ChrisRowland-_Chairman-_Endostart.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Endostart Appoints Christopher Rowland Chairman of the Company\u2019s Board of Directors."}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46214"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46214\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}